BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 31718693)

  • 21. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Matsuda T; Tanaka Y; Ohshiro K; Mori N
    Retrovirology; 2006 Apr; 3():22. PubMed ID: 16603085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation.
    Li Y; Li Y; Zhang H; Shi R; Zhang Z; Liu H; Chen J
    BMC Pulm Med; 2021 Jun; 21(1):190. PubMed ID: 34090412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT5a and STAT6 gene expression levels in multiple sclerosis patients.
    Hatami M; Salmani T; Arsang-Jang S; Davood Omrani M; Mazdeh M; Ghafouri-Fard S; Sayad A; Taheri M
    Cytokine; 2018 Jun; 106():108-113. PubMed ID: 29126764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway.
    Wang SW; Hu J; Guo QH; Zhao Y; Cheng JJ; Zhang DS; Fei Q; Li J; Sun YM
    Oncol Rep; 2014 Nov; 32(5):1991-8. PubMed ID: 25216185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling.
    Xiong H; Chen ZF; Liang QC; Du W; Chen HM; Su WY; Chen GQ; Han ZG; Fang JY
    J Cell Mol Med; 2009 Sep; 13(9B):3668-79. PubMed ID: 20196786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cross-talk between LncRNAs and JAK-STAT signaling pathway in cancer.
    Hjazi A; Obaid RF; Ali SS; Abdullaev B; Alsaab HO; Huldani H; Romero-Parra RM; Mustafa YF; Hussien BM; Saadoon SJ
    Pathol Res Pract; 2023 Aug; 248():154657. PubMed ID: 37451194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
    Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance.
    Park SY; Lee CJ; Choi JH; Kim JH; Kim JW; Kim JY; Nam JS
    J Exp Clin Cancer Res; 2019 Sep; 38(1):399. PubMed ID: 31511084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OTX1 silencing suppresses ovarian cancer progression through inhibiting the JAK/STAT signaling.
    Zhang Q; Li X; Ren L; Gu X; Xiao N; Li N
    Tissue Cell; 2023 Jun; 82():102082. PubMed ID: 37027968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
    Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
    Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells.
    Xiong H; Zhang ZG; Tian XQ; Sun DF; Liang QC; Zhang YJ; Lu R; Chen YX; Fang JY
    Neoplasia; 2008 Mar; 10(3):287-97. PubMed ID: 18320073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer.
    Shi D; Zheng H; Zhuo C; Peng J; Li D; Xu Y; Li X; Cai G; Cai S
    Med Oncol; 2014 Jul; 31(7):31. PubMed ID: 24908062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
    Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ECPIRM, a Potential Therapeutic Agent for Cutaneous T-Cell Lymphoma, Inhibits Cell Proliferation and Promotes Apoptosis via a JAK/STAT Pathway.
    Yang H; Ma P; Cao Y; Zhang M; Li L; Wei J; Tao L; Qian K
    Anticancer Agents Med Chem; 2018; 18(3):401-411. PubMed ID: 28356009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
    Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
    Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LNRRIL6, a novel long noncoding RNA, protects colorectal cancer cells by activating the IL-6-STAT3 pathway.
    Wang J; Zhou J; Jiang C; Zheng J; Namba H; Chi P; Asakawa T
    Mol Oncol; 2019 Nov; 13(11):2344-2360. PubMed ID: 31246342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells.
    Chen J; Gong C; Mao H; Li Z; Fang Z; Chen Q; Lin M; Jiang X; Hu Y; Wang W; Zhang X; Chen X; Li H
    Int J Oncol; 2018 Aug; 53(2):567-578. PubMed ID: 29901191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of long non-coding RNA SBDSP1 suppresses tumor growth and invasion in colorectal cancer.
    Shi D; Liang L; Zheng H; Cai G; Li X; Xu Y; Cai S
    Biomed Pharmacother; 2017 Jan; 85():355-361. PubMed ID: 27890432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.